BioCryst Pharmaceuticals
BCRX
BCRX
116 hedge funds and large institutions have $443M invested in BioCryst Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 23 reducing their positions, and 23 closing their positions.
Holders
116
Holders Change
-4
Holders Change %
-3.33%
% of All Funds
2.63%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
19
Increased
45
Reduced
23
Closed
23
Calls
$907K
Puts
$577K
Net Calls
+$330K
Net Calls Change
+$4.06M
Top Buyers
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$0 |
| 2 |
ACA
2
Avoro Capital Advisors
New York
|
$1.67M |
| 3 |
VMI
3
VHCP Management II
New York
|
$12.2M |
| 4 |
4
D.E. Shaw & Co
New York
|
$4.61M |
| 5 |
GTC
5
Ghost Tree Capital
New York
|
$0 |
